Read More Pharma Industry News Bristol Myers Squibb gets Reblozyl EC approval for anemia associated with NTD beta thalassemia Bristol Myers Squibb (BMY) has secured full marketing authorization for Reblozyl (luspatercept) from the European Commission (EC) for… byPallavi MadhirajuMarch 4, 2023